Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Tirelli (Pavia, Italy), V. Morandi (Pavia, Italy), I. Campo (Pavia, Italy), G. Zanframundo (Pavia, Italy), C. Marioli (Pavia, Italy), N. Grossi (Pavia, Italy), R. Dore (Pavia, Italy), A. Valentini (Pavia, Italy), L. Cavagna (Pavia, Italy), F. Meloni (Pavia, Italy). Clinical, functional and radiologic progression in Interstitial pneumonia with autoimmune features (IPAF): a prospective cohort-study. 803

Member's Comments

No comment yet.

Related content which might interest you: Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Interstitial pneumonia with autoimmune features (IPAF): a clinical entity? Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Clinical features of patients with desquamative interstitial pneumonia: Association with autoimmune disorders Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Clinical significance of histological UIP pattern in interstitial pneumonia with autoimmune features (IPAF) Source: International Congress 2017 – Novel and old entities Year: 2017 Impact of comorbidities in interstitial pneumonia with autoimmune features (IPAF) Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features Source: International Congress 2016 – Connective tissue disorders Year: 2016 Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened Source: Eur Respir J 2016; 47: 1293-1295 Year: 2016 Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened Source: Eur Respir J 2016; 47: 1295-1296 Year: 2016 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Prognostic impact and clinical characteristics of Interstitial Pneumonia with Autoimmune features (IPAF) in a multidisciplinary setting Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Interstitial pneumonia with autoimmune features: a new classification still on the move Source: Eur Respir Rev, 27 (148) 180047; 10.1183/16000617.0047-2018 Year: 2018 Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study Source: Virtual Congress 2021 – Imaging in COVID-19 Year: 2021 Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort. Source: International Congress 2017 – Novel and old entities Year: 2017 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Outcomes of patients with progressive fibrosing interstitial lung disease (PF-ILD) – data from a prospective ILD registry Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021